Linus Tan, Ph.D., joined Vivo with a fundamental and translational research background in biomedical field. Prior to Vivo, Linus worked for China Asset Management Co., Ltd. as a senior associate focusing on Biotech, Vaccine & CRO industries. He also served as research assistant for Novo Nordisk A/S in discovery and optimization of next-generation peptide drug candidates.
Linus has conducted research in peptide drug discovery and ubiquitin signaling pathway and published his research in multiple peer-reviewed journals, including JACS, ChemComm and CCL, etc. Linus received his B.S. in Organic Chemistry from University of Science & Technology of China and Ph.D. in Chemical Biology from Tsinghua University.